Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08.
about
CD28 co-stimulation in T-cell homeostasis: a recent perspectiveEmerging Therapies for Rheumatoid ArthritisAutosomal dominant immune dysregulation syndrome in humans with CTLA4 mutationsTGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse ModelTCR signaling fuels T(reg) cell suppressor function.T Cells of Infants Are Mature, but Hyporeactive Due to Limited Ca2+ Influx.Interleukin-2/Anti-Interleukin-2 Immune Complex Attenuates Cardiac Remodeling after Myocardial Infarction through Expansion of Regulatory T Cells.Regulatory T cells ameliorate intrauterine growth retardation in a transgenic rat model for preeclampsiaUnderstanding the CD28/CTLA-4 (CD152) pathway and its implications for costimulatory blockade.Stabilizing human regulatory T cells for tolerance inducing immunotherapy.Role of receptor occupancy assays by flow cytometry in drug development.Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy.CD28 Costimulation: From Mechanism to Therapy.Drug Development of Therapeutic Monoclonal Antibodies.Cytokines: The Good, the Bad, and the Deadly.In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice.The rise and fall of the CD28 superagonist TGN1412 and its return as TAB08: a personal account.Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris.Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells.Short-term cytokine stimulation reveals regulatory T-cells with down-regulated Foxp3 expression in human peripheral blood.In vitro polyclonal activation of conventional T cells with a CD28 superagonist protects mice from acute graft versus host disease.The return of the prodigal son and the extraordinary development route of antibody TGN1412 - lessons for drug development and clinical pharmacology.Characterization of T-cell subpopulations in patients with chronic rhinosinusitis with nasal polyposis.Self-Recognition Sensitizes Mouse and Human Regulatory T Cells to Low-Dose CD28 Superagonist Stimulation.A non-conserved amino acid variant regulates differential signalling between human and mouse CD28.CD28 between tolerance and autoimmunity: the side effects of animal models.
P2860
Q27007031-5E3C6FBD-956E-43FD-BBB8-98BF4DA4684DQ28078943-BA289EED-ADEB-4BBC-979C-086934C588E3Q28250000-753F39D9-4404-46D4-99ED-35C6F24106BAQ35950889-1F8498FC-FE6E-4DA2-A439-792695503C98Q36041794-0A10DB3C-2CF7-4873-955C-C499891EED72Q36205480-194D3B53-9091-4FE0-AD41-46F2A4D67904Q36814572-2CD97E74-CC70-4946-A158-09B943202754Q37451538-C51029DA-177B-4833-9838-3DF83EAFE952Q38237428-4D6C9CFA-E0E2-47CD-858C-0CFDDCE88D71Q38644779-7B759A0A-7A12-4CC8-B4E8-9448D9E87713Q38679593-C12D3A5F-B1BA-4B5C-94CD-F47FA12C9A0CQ38691672-BAFCC596-9FD9-4127-B60C-1DAC37A0B15CQ38837466-5390C84B-2DCE-4CE2-B280-75C98D954F11Q38876360-AFACDE66-21C6-4776-AA79-A2B7FD6849C5Q39002175-3E01A929-6714-4A02-A659-5049D7190292Q40164249-A77DFA42-97D4-4ECE-A43E-53905F555B19Q40748706-3B6DB6CF-E6C8-4C28-996E-EC3907887BB8Q41055584-ED18A56C-AD22-4D2F-B9AD-7AB39B00FE86Q41791447-ACCC87D9-CF4D-47AF-9E3A-0486A7E3BC8FQ41918204-2B99D345-B059-419E-99AD-83CD495B5B68Q42146101-393DBCDE-4391-4D11-90E7-0DD72CBD25E4Q42560014-85812F0F-4DBF-47E1-AC3E-02E186AC3046Q47120377-C1F23A7D-9AA6-4A86-8AF5-C1BCFABB3D05Q49426485-9616B991-99F9-4335-BEA6-D996113E22FBQ55174942-47911469-5880-486D-984E-9B4799B14592Q55286510-891E166D-1A58-447F-98DA-13409E29389C
P2860
Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Human regulatory T cells are s ...... 28 superagonist TGN1412/TAB08.
@en
Human regulatory T cells are s ...... 28 superagonist TGN1412/TAB08.
@nl
type
label
Human regulatory T cells are s ...... 28 superagonist TGN1412/TAB08.
@en
Human regulatory T cells are s ...... 28 superagonist TGN1412/TAB08.
@nl
prefLabel
Human regulatory T cells are s ...... 28 superagonist TGN1412/TAB08.
@en
Human regulatory T cells are s ...... 28 superagonist TGN1412/TAB08.
@nl
P2093
P2860
P356
P1476
Human regulatory T cells are s ...... 28 superagonist TGN1412/TAB08.
@en
P2093
Alexey A Matskevich
Dmitry Tyrsin
Paula S Römer
Paula Tabares
Sergej Chuvpilo
Susanne Berr
Thomas Hünig
Yury Fedotov
P2860
P304
P356
10.1002/EJI.201343967
P407
P577
2014-02-01T00:00:00Z